English
  1. Home
  2. Stocks
  3. Remus Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Remus Pharmaceuticals Share Price Remus Pharmaceuticals

    Small Cap
    ₹7,203.85
    -228.8 (-3.08%)
    10 May, 2024 01:15 BSE: NSE: REMUSISIN: INE0O5T01011

    Start SIP in Remus Pharmaceuticals

    Start SIP

    Remus Pharmaceuticals Performance

    Day Range

    • Low 7,155
    • High 7,550
    ₹ 7,203

    52 Week Range

    • Low 1,711
    • High 8,747
    ₹ 7,203
    • Open Price7,550
    • Previous Close7,433
    • Volume1675

    Remus Pharmaceuticals Share Price

    • Over 1 Month +18.31%
    • Over 3 Month -2.49%
    • Over 6 Month +31.4%
    • Over 1 Year +486.16%

    Remus Pharmaceuticals Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 1,061
    Price to Book Ratio 55.5
    EPS 57.7
    Dividend 0.1
    Relative Strength Index 53.29
    Money Flow Index 74.32
    MACD Signal 364.8
    Average True Range 531.35
    Remus Pharmaceuticals Financials
    IndicatorMar 2023
    Total Revenue Annual Cr 47
    Operating Expenses Annual Cr 34
    Operating Profit Annual in Cr 11
    Depreciation Cr 0
    Interest Annual Cr 0
    Tax Annual Cr 3
    Net Profit Annual Cr 9
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 5
    Cash from Investing Activity Annual Cr -15
    Cash from Financing Annual Activity Cr 12
    Net Cash Flow Annual Cr 2
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 19
    Fixed Assets Annual Cr 3
    Total Non Current Assets Annual Cr 23
    Total Current Assets Annual Cr 11
    Total Assets Annual Cr 35
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 176
    ROE Annual % 44
    ROCE Annual % 44
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 27
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Remus Pharmaceuticals

    Remus Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹7,203.85
    -228.8 (-3.08%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹7,110.55
    • 50 Day
    • ₹6,679.84
    • 100 Day
    • ₹6,332.14
    • 200 Day
    • ₹5,528.53
    • 20 Day
    • ₹6,945.24
    • 50 Day
    • ₹6,351.34
    • 100 Day
    • ₹6,547.21
    • 200 Day
    • ₹5,689.14

    Remus Pharmaceuticals Resistance and Support

    PIVOT
    ₹7,302.95
    Resistance
    First Resistance 7,450.90
    Second Resistance 7,697.95
    Third Resistance 7,845.90
    RSI 53.29
    MFI 74.32
    MACD Single Line 364.80
    MACD 357.85
    Support
    First Resistance 7,055.90
    Second Resistance 6,907.95
    Third Resistance 6,660.90

    Remus Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,675 107,502 64.18
    Week 3,030 215,009 70.96
    1 Month 5,162 306,046 59.29
    6 Month 2,580 173,158 67.11

    Remus Pharmaceuticals Result Highlights

    Remus Pharmaceuticals Synopsis

    NSE-Medical-Whlsle Drg/Suppl

    Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.
    Market Cap 1,055
    Sales 45
    Shares in Float 0.04
    No of funds 3
    Yield 0.03
    Book Value 40.6
    U/D Vol ratio 1.1
    LTDebt / Equity 37
    Alpha 0.55
    Beta 1.5

    Remus Pharmaceuticals

    Owner NameMar-24Sep-23
    Promoters 70.6%69.61%
    Foreign Portfolio Investors 3.25%2.38%
    Financial Institutions/ Banks
    Individual Investors 20.54%21.15%
    Others 5.61%6.86%

    Remus Pharmaceuticals Management

    Name Designation
    Mr. Swapnil Jatinbhai Shah Chairman & Wholetime Director
    Mr. Arpit Deepakkumar Shah Managing Director
    Mrs. Anar Swapnil Shah Whole Time Director
    Ms. Roma Vinodbhai Shah Whole Time Director
    Mr. Balwant Purohit Independent Director
    Mrs. Sanjana Sanjeev Shah Independent Director
    Mr. Vishrut Chandramauli Pathak Independent Director

    Remus Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Remus Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-04-23 Bonus issue & Interim Dividend
    2024-04-22 Interim Dividend
    Date Purpose Remarks
    2024-05-02 INTERIM Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24.
    2023-10-28 INTERIM Rs.0.00 Interim Dividend of Rs. 2 per equity share.

    Remus Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Remus Pharmaceuticals FAQs

    What is Share Price of Remus Pharmaceuticals ?

    Remus Pharmaceuticals share price is ₹7,203 As on 10 May, 2024 | 01:01

    What is the Market Cap of Remus Pharmaceuticals ?

    The Market Cap of Remus Pharmaceuticals is ₹1061.1 Cr As on 10 May, 2024 | 01:01

    What is the P/E ratio of Remus Pharmaceuticals ?

    The P/E ratio of Remus Pharmaceuticals is As on 10 May, 2024 | 01:01

    What is the PB ratio of Remus Pharmaceuticals ?

    The PB ratio of Remus Pharmaceuticals is 55.5 As on 10 May, 2024 | 01:01

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.